TrumpRx and the New Wave of Direct Drug Sales

The announcement by the U.S. federal government of a new plan to introduce direct-to-customer (DTC) access for medications has some serious implications for employers, brokers, and self-insured plan administrators. This article focuses on the likely effects of cost containment and strategic sourcing of the TrumpRx plans. The question remains: Do we know enough to claim that TrumpRx […]
Will TrumpRx Lower Your Prescription Costs? Here’s the Truth.

At the beginning of October 2025, the Trump administration announced plans for direct-to-consumer prescription drugs, called TrumpRx. Although facts are still hard to come by, it appears that at its core, TrumpRx and DTC, which is supposed to be launched sometime in 2026, is meant to create a government-run portal that will steer patients directly […]
Why Women’s Aging Can Hold the Key to Longevity and Healthier Lives for All

For too long, aging has been framed as a male-dominated story of biohacks and trophies. Dr. Jennifer Garrison, an assistant professor of cellular and molecular pharmacology at the University of California, San Francisco, was reported in a New York Times article saying, “Males have always been the baseline for longevity. Females should be.” She talked […]
What New U.S. Tariffs Mean for You: A Message From Our Founder

With new tariffs making headlines, I know many of our U.S. customers are concerned, wondering if their medicines will cost more, if shipping will slow down, or if access could be at risk. Changes like these can feel unsettling, but we’ve navigated challenges before and always found ways to adapt. My goal here is to […]
How Digital Twins Could Change Clinical Drug Trials

What is a digital twin, and how can it speed up drug trials? While researching health trends expected to boom in the next few years, I was particularly fascinated by the use of artificial intelligence (AI) and digital health technologies. These are changing the landscape of medicine, offering new ways to personalize patient care and […]
GLP-1 Agonists: A Potential Game-Changer for Addictive Behavior

A complicated research paper was published just a few weeks ago on the Nature website that introduces some exciting new findings about how GLP-1 agonist medications like semaglutide, Ozempic, Mounjaro, Wegovy, and trizepatide may be capable of doing far more than just treating diabetes and obesity. One of the most impressive findings indicates that addictive […]
Five common misbeliefs about COVID-19 and vaccines

Do people let false claims about health issues get in their way? It is quite disturbing to learn that reliable research into public attitudes toward health reveals substantial misconceptions and willingness to believe false claims about health issues as “the whole truth.” One of these research efforts was backed by the reputable organization KFF (derived […]
The Start-Up Nation’s Cure: A Look at Israeli Healthcare Technology Innovation

As we approach Israel’s 76th birthday on May 15th, we can look back on some of the exceptional achievements made by the Start-up Nation in healthcare, science, and commerce, thanks to the work done here in Israel by universities, institutes, individual scientists, and companies. It’s no secret that Israel punches far above its weight regarding […]
World Obesity Week 2024

As we have highlighted previously, World Obesity Week used to be scheduled in November each year. This year, by consensus of the many governmental and international bodies engaged in public health promotion, it has been moved to March, with the start of Obesity Care Week, which runs from the 4th to the 8th of March. […]
News about health, medicines and treatments – January 2024

The start of 2024 brought exciting news about health, medicines and treatments. Here are three of the most interesting announcements that appeared on news websites in January: Hypertension A study published in one of the leading journals dealing with cardiology brought up some unexpected results. It seems that hypertension may be infectious, in the broadest […]


